In the Media

Tech Explorist reporter Amit Malewar writes that researchers from Singapore-MIT Alliance for Research and Technology (SMART) have “demonstrated a new way to manufacture human red blood cells (RBCs) that cuts the culture time by half compared to existing methods.”